NasdaqGS - Nasdaq Real Time Price USD

Utah Medical Products, Inc. (UTMD)

Compare

60.91

-0.01

(-0.02%)

At close: January 10 at 4:00:01 PM EST

60.91

0.00

(0.00%)

After hours: January 10 at 4:01:13 PM EST

Capital Allocation Trends At Utah Medical Products (NASDAQ:UTMD) Aren't Ideal

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Simply Wall St. 9 days ago

UTMD
-0.02%
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be Increased To $0.305

Utah Medical Products, Inc. ( NASDAQ:UTMD ) will increase its dividend from last year's comparable payment on the 3rd...

Simply Wall St. 29 days ago

UTMD
-0.02%
The past three years for Utah Medical Products (NASDAQ:UTMD) investors has not been profitable

Many investors define successful investing as beating the market average over the long term. But in any portfolio...

Simply Wall St. last month

UTMD
-0.02%
Utah Medical Products' (NASDAQ:UTMD) Soft Earnings Don't Show The Whole Picture

Shareholders appeared unconcerned with Utah Medical Products, Inc.'s ( NASDAQ:UTMD ) lackluster earnings report last...

Simply Wall St. last month

UTMD
-0.02%
With 66% institutional ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, Utah Medical Products' stock price might be vulnerable...

Simply Wall St. 2 months ago

UTMD
-0.02%
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD ...

ACCESSWIRE 2 months ago

UTMD
-0.02%
Utah Medical Q3 Earnings Decline Y/Y on Lower OEM Sales

UTMD reports a 5.2% EPS decline in Q3 2024, with revenues declining 20% due to reduced OEM and Filshie sales. Cost controls helped stabilize profit margins.

Zacks 2 months ago

UTMD
-0.02%
Utah Medical: Q3 Earnings Snapshot

MIDVALE, Utah (AP) — Utah Medical Products Inc. UTMD) on Tuesday reported earnings of $3.6 million in its third quarter. The Midvale, Utah-based company said it had net income of $1.02 per share.

Associated Press Finance 2 months ago

UTMD
-0.02%
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were weaker on the top line, but better on the bottom ...

ACCESSWIRE 2 months ago

UTMD
-0.02%
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical

Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical are included in this Analyst Blog.

Zacks 4 months ago

AZN

DIS

V
Top Analyst Reports for Linde, AstraZeneca & Walt Disney

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and The Walt Disney Company (DIS), as well as two micro-cap stocks FitLife Brands, Inc. (FTLF) and Utah Medical Products, Inc. (UTMD).

Zacks 4 months ago

DIS

AZN

V
Will Weakness in Utah Medical Products, Inc.'s (NASDAQ:UTMD) Stock Prove Temporary Given Strong Fundamentals?

Utah Medical Products (NASDAQ:UTMD) has had a rough month with its share price down 5.1%. However, stock prices are...

Simply Wall St. 4 months ago

UTMD
-0.02%
Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders ...

ACCESSWIRE 5 months ago

UTMD
-0.02%
Utah Medical Products Second Quarter 2024 Earnings: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

Utah Medical Products ( NASDAQ:UTMD ) Second Quarter 2024 Results Key Financial Results Revenue: US$10.4m (down 19...

Simply Wall St. 5 months ago

UTMD
-0.02%
Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales

Utah Medical (UTMD) reports a 19.2% revenue decline in 2Q24, with EPS down 15.3% due to lower sales to major customers. Despite this, profit margins remained stable.

Zacks 5 months ago

UTMD
-0.02%
Utah Medical: Q2 Earnings Snapshot

MIDVALE, Utah (AP) — Utah Medical Products Inc. UTMD) on Thursday reported earnings of $3.5 million in its second quarter. The Midvale, Utah-based company said it had profit of 98 cents per share.

Associated Press Finance 5 months ago

UTMD
-0.02%
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024

SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results which reflect a substantial decline in revenues. ...

ACCESSWIRE 5 months ago

UTMD
-0.02%
Investors in Utah Medical Products (NASDAQ:UTMD) have unfortunately lost 27% over the last year

Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can...

Simply Wall St. 6 months ago

UTMD
-0.02%
With 65% ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) boasts of strong institutional backing

Key Insights Given the large stake in the stock by institutions, Utah Medical Products' stock price might be vulnerable...

Simply Wall St. 7 months ago

UTMD
-0.02%
Zacks Initiates Coverage of UTMD With Neutral Recommendation

Explore why Zacks rates UTMD with a "Neutral" recommendation, being the first on Wall Street to initiate coverage on the stock. Learn about UTMD's financial stability, diverse product portfolio, and market opportunities, balanced against key challenges in the competitive medical device industry.

Zacks 7 months ago

UTMD
-0.02%

Performance Overview

Return	UTMD	S&P 500
YTD	+0.02%	-1.35%
1-Year	-25.76%	+22.51%
3-Year	-30.29%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Utah Medical Products, Inc. (UTMD)

Capital Allocation Trends At Utah Medical Products (NASDAQ:UTMD) Aren't Ideal

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be Increased To $0.305

The past three years for Utah Medical Products (NASDAQ:UTMD) investors has not been profitable

Utah Medical Products' (NASDAQ:UTMD) Soft Earnings Don't Show The Whole Picture

With 66% institutional ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) is a favorite amongst the big guns

Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

Utah Medical Q3 Earnings Decline Y/Y on Lower OEM Sales

Utah Medical: Q3 Earnings Snapshot

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical

Top Analyst Reports for Linde, AstraZeneca & Walt Disney

Will Weakness in Utah Medical Products, Inc.'s (NASDAQ:UTMD) Stock Prove Temporary Given Strong Fundamentals?

Utah Medical Products, Inc. Announces Quarterly Dividend

Utah Medical Products Second Quarter 2024 Earnings: EPS: US$0.98 (vs US$1.16 in 2Q 2023)

Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales

Utah Medical: Q2 Earnings Snapshot

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024

Investors in Utah Medical Products (NASDAQ:UTMD) have unfortunately lost 27% over the last year

With 65% ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) boasts of strong institutional backing

Zacks Initiates Coverage of UTMD With Neutral Recommendation

Performance Overview